Olivier Ast

HuntX Pharma has been incorporated in december 2022 with the objective of being Pionneer and Leader in addressing new therapeutical targets to fight axonal transport defect related diseases with Huntington disease as a first indication. #HuntXPharma

HuntX Pharma has been incorporated in december 2022 with the objective of being Pionneer and Leader in addressing new therapeutical targets to fight axonal transport defect related diseases with Huntington disease as a first indication. #HuntXPharma

Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics that helps clients navigate complex product development issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments in these markets. Bionest consultants are valued strategic partners who have helped more than 250 companies around the world build high-value product portfolios, optimize development approaches and prepare for commercial success. Our track record includes more than 500 successful projects consisting of innovative, creative and differentiated action plans grounded in in-depth market and financial analysis. Our collaborative and hands-on approach allows us to be flexible and tailor our approach to your needs. This results in practical solutions complete with deep analysis, clear recommendations, and solid strategies that recognize the process of gaining internal alignment at the corporate, portfolio and brand levels. Using our creativity and insights combined with deep content experience and a global focus, we have the right knowledge and experience to help you succeed.

Societe Generale is one of the leading European financial services groups. Based on a diversified and integrated banking model, the Group combines financial strength and proven expertise in innovation with a strategy of sustainable growth. Committed to the positive transformations of the world’s societies and economies, Societe Generale and its teams seek to build, day after day, together with its clients, a better and sustainable future through responsible and innovative financial solutions. Active in the real economy for over 150 years, with a solid position in Europe and connected to the rest of the world, Societe Generale has over 117,000 members of staff in 66 countries and supports on a daily basis 25 million individual clients, businesses and institutional investors around the world by offering a wide range of advisory services and tailored financial solutions. The Group is built on three complementary core businesses: - French Retail Banking which encompasses the SG and Boursorama brands. Each offers a full range of financial services with omnichannel products at the cutting edge of digital innovation; - International Retail Banking, Insurance and Financial Services, with networks in Africa, Central and Eastern Europe and specialised businesses that are leaders in their markets; - Global Banking and Investor Solutions, which offers recognised expertise, key international locations and integrated solutions. Societe Generale is included in the principal socially responsible investment indices: DJSI (Europe), FTSE4Good (Global and Europe), Bloomberg Gender-Equality Index, Refinitiv Diversity and Inclusion Index, Euronext Vigeo (Europe and Eurozone), STOXX Global ESG Leaders indexes, and the MSCI Low Carbon Leaders Index (World and Europe).